Regulations

D’Ruiz of DSM-Firmenich Represents the Suncare Industry on Capitol Hill

Testimony highlights the urgent need for innovation in sunscreen standards to combat the fastest-growing cancer in America—skin cancer.

Author Image

By: TOM BRANNA

Editor

Carl D’Ruiz MPH represented DSM-Firmenich Beauty & Care as well as the Personal Care Products Council at an Energy and Commerce Health Subcommittee hearing on FDA OTC sunscreen regulations and OMUFA 2 reauthorization. D’Ruiz’s testimony highlighted the urgent need for innovation in sunscreen standards to combat the fastest-growing cancer in America—skin cancer. With 6.1 million adults treated annually at a cost of nearly $9 billion, the importance of effective sunscreens ca...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters

Topics